Antibe Announces Results of 2023 Annual Meeting
TORONTO — Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation…
Source: financialpost.com
📰 Walt Macnee News
Walt Macnee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Walt Macnee. Real-time updates on events, politics, business and more.
Antibe Announces Results of 2023 Annual Meeting
Antibe Therapeutics Inc. , a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation therapies to target inflammation, is pleased to announce the results of its...
Source: marketscreener.com
Antibe Announces Results of 2022 Annual Meeting
TORONTO--(BUSINESS WIRE)--$ATBPF--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce the results of its annual meeting of shareholders (the “Meeting”) held ear...
Source: pharmiweb.com